2013
DOI: 10.1016/s0924-977x(13)70720-x
|View full text |Cite
|
Sign up to set email alerts
|

P.3.c.004 A mechanism of antipsychotic treatment failure and its reversal

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Decreased DA levels can impair the DA-mediated autoinhibition and may predispose to DA supersensitivity, leading to psychosis in humans or schizophrenia-like symptoms in animals. Of note, the role of decreased monoamine levels in DA supersensitivity has already been suggested to mediate antipsychotic treatment failure in animal models (Amato, 2015; Amato et al, 2011a, 2011b, 2013, 2014) and in humans (Howes and Kapur, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Decreased DA levels can impair the DA-mediated autoinhibition and may predispose to DA supersensitivity, leading to psychosis in humans or schizophrenia-like symptoms in animals. Of note, the role of decreased monoamine levels in DA supersensitivity has already been suggested to mediate antipsychotic treatment failure in animal models (Amato, 2015; Amato et al, 2011a, 2011b, 2013, 2014) and in humans (Howes and Kapur, 2014).…”
Section: Discussionmentioning
confidence: 99%